ArticleNature cancer2026

IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.

Lukas Bunse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.